TriSalus Life Sciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. TriSalus Life Sciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 49% to $18,511,000. Profit margin reached -319%. Total operating expenses were $70,056,000.

Profit Margin

TriSalus Life Sciences, Inc. (NASDAQ:TLSI): Profit margin
2020 5.43M -31.83M -585.76%
2021 8.40M -28.84M -343.35%
2022 12.39M -47.18M -380.6%
2023 18.51M -59.03M -318.93%

TLSI Income Statement (2020 – 2023)

2023 2022 2021 2020
Revenue
Revenue
18.51M12.39M8.40M5.43M
Cost of revenue
2.60M2.25M1.19M2.19M
Gross profit
15.90M10.14M7.20M3.23M
Operating exp.
Research and development
29.51M21.35M14.22M15.82M
Selling and marketing
17.03M12.73M8.26M6.18M
Total operating expenses
70.05M46.57M31.24M29.02M
Operating income
-54.15M-36.43M-24.03M-25.64M
Other income (expenses), net
-4.87M-10.91M-3.04M-6.18M
Income before tax
-59.02M-47.17M-28.84M-31.82M
Income tax expense
9K9K3K4K
Net income
-59.03M-47.18M-28.84M-31.83M
Earnings per share
Basic EPS
-6.73-1.59-0.92-1.04
Diluted EPS
-6.73-1.59-0.92-1.04
Data source